Bachem Holding AG

Swiss Stock Exchange BANB.SW

Bachem Holding AG Shares (Diluted, Weighted) for the year ending December 31, 2023: 74,688,455

Bachem Holding AG Shares (Diluted, Weighted) is 74,688,455 for the year ending December 31, 2023, a 1.29% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Bachem Holding AG Shares (Diluted, Weighted) for the year ending December 31, 2022 was 73,734,613, a 4.08% change year over year.
Bachem Holding AG Shares (Diluted, Weighted) for the year ending December 31, 2021 was 70,846,745, a 1.23% change year over year.
Bachem Holding AG Shares (Diluted, Weighted) for the year ending December 31, 2020 was 69,986,140, a 1.16% change year over year.
Bachem Holding AG Shares (Diluted, Weighted) for the year ending December 31, 2019 was 69,181,895, a 1.86% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Swiss Stock Exchange: BANB.SW

Bachem Holding AG

CEO	Mr. Thomas Meier
IPO Date	July 17, 1998
Location	Switzerland
Headquarters	Hauptstrasse 144
Employees	2,009
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.

Key trends

Past 5 years